Avacta receives clinical validation of AffiDX SARS-CoV-2 antigen lateral flow test
Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test. Data from the clinical study conducted in Europe on 98 positive COVID-19 samples demonstrate excellent performance in…
Cambridge spin-out HexagonFab secures £1.9m seed funding to launch the Bolt
University of Cambridge spin-out company HexagonFab today announced a £1.9 million seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, and several private investors.
CorrosionRADAR wins prestigious Materials Performance Award
CorrosionRADAR is proud to win the Materials Performance (MP) / Association for Materials Protection and Performance (formerly NACE) Corrosion Innovation of the Year Award for its ground-breaking Predictive Corrosion Under Insulation (CUI) Monitoring System – a next generation technology solution that is transforming global response to the enormous industrial challenges created by…
Businesses urged to apply for Government Restart Grants
South Cambridgeshire businesses affected by the post-Christmas national lockdown can now apply online for the Government’s Restart Grants.
NVIDIA's anticipated acquisition of ARM to be investigated
The Government has annnounced its intention to intervene in the proposed acquisition of ARM with NVIDIA.
Cambridge Index climbs 1.2%
The Cambridge Index rose 326.2 points or 1.2% to close at 28,595.4, as five of the top ten Index heavyweights posted weekly gains to their share prices.
Three-way partnerships deliver transformational projects for SMEs
The Government backed Knowledge Transfer Partnership (KTP) Programme has been supporting industry for over 40 years, embedding knowledge and technology to create more competitive and productive businesses.
Cambridge cyclist completes more than than 400 miles for charity
Cambridge cyclist, Rob Barber, completes 452 miles to raise money for The British Heart Foundation, Cancer Research UK, and Diabetes.
AccountAbility-Plus launches new service to support growing and ambitious businesses
AccountAbility-Plus announces the launch of its latest service, The 300 Club. The 300 Club has been formed to support fledgling and ambitious business owners to grow their business.
COVID-19 vaccines and the seasonal scenario
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a new updated ‘seasonal scenario’ global demand analysis for COVID-19 vaccines.
Is localisation the future of the supply chain?
Elite Electronic Systems writes: In our everyday operations, we speak to hundreds of business leaders about the challenges facing them both during the Coronavirus pandemic & Brexit. A core theme we are hearing is that the COVID-19 outbreak will have a lasting outcome on their supply chains, with many analysing risk management processes, resilience, and agility of their businesses.
Thinking content differently
In a world where everyone is competing to be the expert with their digital content to satisfy the needs and wants of search engines, how can a brand think differently to get ahead?
Tame your computer - take a shortcut to appointments
In her regular series for Cambridge Network members - now in its 15th year - software training expert Karen Roem offers handy tips to help you 'Tame your computer'. This week she describes how to show your appointment page without opening your calendar (Microsoft Outlook).
OpenShift installation in fifteen minutes*
A series of articles by Tier 2 Consulting will help you install and configure an OpenShift cluster on Amazon Web Services (AWS).
Five reasons to exhibit at Cancer Diagnostic Technology Summit 2021
Early detection of cancer and improved survival rates will depend on development of more sensitive diagnostic methods.
Cambridge COVID-19 Test Centre has processed more than 3 million tests
More than 3 million tests have now been processed at the Cambridge COVID-19 Test Centre as part of the University’s extensive response to the pandemic.
Johnson Matthey announces strategic partnership for sustainable battery materials production and secures critical raw materials supply
Johnson Matthey (JM), a global leader in sustainable technologies, today announces significant strategic developments in the commercialisation of eLNO – its portfolio of leading nickel rich advanced cathode materials – which put JM at the forefront of providing a sustainable and secure supply of cathode materials for customers, in line with its vision for a cleaner, healthier world.
Sepura celebrates business award and Investors in People Silver accreditation
Sepura has received two significant awards in quick succession, to round off a year of growth and record revenues.
Metrion Biosciences appoints Mark Keogh as Non-Executive Director
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, today announced the appointment of Mark Keogh as a Non-Executive Director. The appointment follows the Company’s recently announced £2.7m new equity investment led by Gresham House Ventures and is intended to strengthen the Board’s financial and corporate experience, in support of the Company’s…
Industrial supply in Cambridge reaches low level as science and tech sector grows
Bidwells Spring 2021 report reveals that the Cambridge Industrial market supply has reached its lowest level in more than 15 years. The availability rate has dipped to 3.7%, leaving only a few immediate options for occupiers seeking space.
Adaptate Biotherapeutics raises $18 million in Series A2 funding
London, UK... Adaptate Biotherapeutics, a company focused on developing antibody-based therapeutics for modulation of gamma delta T cells, today announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million (circa. £13 million). This funding brings the total raised since Adaptate’s inception in late…
ERS Genomics and NUVISAN ICB sign CRISPR/Cas9 licence agreement
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
Flagship AI company Luminance selected for prestigious Tech Nation Future Fifty programme
Leading British AI company Luminance has been selected for this year’s coveted Tech Nation Future Fifty programme which celebrates the UK’s most successful technology companies.
Phico Therapeutics awarded up to $18.2m CARB-X funding to advance SASPject antibacterial therapy
Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has been awarded a grant of up to $18.2 million USD (circa. £13.2 million GBP) from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit partnership dedicated to accelerating…
Businesses shun litigation for conciliation amid pandemic – but a rise in legal claims in 2021 is likely, finds EY research
UK businesses have avoided using litigation to resolve commercial disputes during the COVID-19 pandemic, instead turning to negotiation and mediation, according to new research published today by EY.